Navigation Links
Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
Date:10/24/2008

" target="_new">http://www.vaxart.com) is a privately held biotechnology company focused on the development of oral vaccines. Vaxart's proprietary approach is ideally suited for modular creation of vaccines, enabling the company to reduce development risk. Vaxart intends to apply its platform to develop a first-in-class vaccine for pandemic influenza, as well as creating oral alternatives to current vaccines such as annual influenza and HPV. The company expects to begin clinical testing of its pandemic flu vaccine in 2009.

Contact: Michele Parisi

for Vaxart

925/864-5028

ir-pr@vaxart.com


'/>"/>
SOURCE Vaxart Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
2. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
3. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
4. Grid Dynamics Demonstrates Linear Scalability up to 512 Nodes with GridGain Software on Amazon EC2 Cloud
5. First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
6. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
7. ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer
8. Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial
9. ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
10. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions
11. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... and CAMBRIDGE, Mass. and REYKJAVIK, Iceland ... , a precision medicine company using the genome to ... selected by Genomics England (GeL) to provide ... rare disease and cancer patients as part of the ... the UK National Health Service (NHS). ...
(Date:6/3/2015)... GEA's Panther™ NS3006L is a ... fully-equipped laboratory unit that is designed for continuous operation ... plants. The Panther™ NS3006L achieves the same results as ... easy installation with simple operation, quick maintenance and is ... used in many different industries, such as food, dairy, ...
(Date:6/2/2015)... - Shell today celebrated the North American launch of an ... exhibit the size of a city block in New ... and the public, and special appearances by industry leaders ... the best total engine protection by addressing three prominent ... corrosion. "With the launch of Shell V-Power ...
(Date:6/2/2015)... , Jun. 02, 2015 Tauriga Sciences, ... diversified life sciences company with interests in the ... synthetic biology platform technology, today announced that it ... Co-Investment, LLC ("Typenex") in exchange for a one-time ... 2015, the Company and Typenex entered into a ...
Breaking Biology Technology:WuXi NextCODE Wins Genomics England Clinical Interpretation Tender in both Rare Disease and Cancer 2GEA Announces the Panther™ NS3006L, a Self-Contained, Fully-Equipped Laboratory Homogenizer Well Suited for Pilot Plants 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 4Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 3Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 4
... Chemotherapy-Induced Nausea and Vomiting, According to a New Report from ... ... 2008 Decision Resources, one,of the world,s leading research and advisory ... Emend for,Injection/Ivemend combined with 5-HT3 RA, is positioned to earn,gold-standard status ...
... DIEGO, April 9, 2008 ADVENTRX,Pharmaceuticals, Inc. (Amex: ... appointed,Jose Hechavarria to the new position of vice ... leading the company,s planned,commercial manufacturing operations., "We ... team," said Evan M.,Levine, ADVENTRX chief executive officer. ...
... by Johns Hopkins researchers has solved important puzzles concerning ... that could lead to a new type of antibiotics. ... Current Biology, the scientists reported how a belt-like structure ... to produce two offspring, can be disabled by a ...
Cached Biology Technology:New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting 2New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting 3ADVENTRX Appoints Vice President of Manufacturing 2ADVENTRX Appoints Vice President of Manufacturing 3Solving the Z ring's mysteries may lead to new antibiotics 2Solving the Z ring's mysteries may lead to new antibiotics 3
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a ... established helmet producer, announced today that they will expand ... the world,s first bio-sensing cycling helmet and the first ... in two new colors in order to give cyclists ... product. In addition, LifeBEAM and Lazer announced their plan ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... setting aside land and marine territories as "protected areas" ... a comprehensive assessment published today in the journal ... growth of protected land and marine areas worldwide - ... million square kilometers of land and 2 million square ...
... YORK (July 28, 2011) -- The ability to tag proteins ... inside cells so revolutionized the understanding of protein biology that ... Prizes in 2008. Now, researchers at Weill Cornell Medical College ... mysterious workings of the various forms of cellular RNA. ...
... expected to be highly efficient, thinner, more flexible, cheaper and ... This could pave the way for them to be the ... Technological University (NTU) today announced that it is investing close ... new research centre that will pioneer the development of such ...
Cached Biology News:Ongoing global biodiversity loss unstoppable with protected areas alone: Study 2Ongoing global biodiversity loss unstoppable with protected areas alone: Study 3Ongoing global biodiversity loss unstoppable with protected areas alone: Study 4Breakthrough lights way for RNA discoveries 2Breakthrough lights way for RNA discoveries 3NTU unveils new center to develop solar cells and clean energy systems of tomorrow 2NTU unveils new center to develop solar cells and clean energy systems of tomorrow 3
Recombinant Mouse MMP-9, CF...
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
TAR DNA binding protein...
Biology Products: